Universal anti-neuraminidase antibody inhibiting all influenza A subtypes

被引:98
|
作者
Doyle, Tracey M. [1 ,6 ,7 ]
Hashem, Anwar M. [1 ,3 ,4 ]
Li, Changgui [5 ]
Van Domselaar, Gary [2 ]
Larocque, Louise [1 ]
Wang, Junzhi [5 ]
Smith, Daryl [1 ]
Cyr, Terry [1 ]
Farnsworth, Aaron [1 ]
He, Runtao [2 ]
Hurt, Aeron C. [8 ]
Brown, Earl G. [6 ,7 ]
Li, Xuguang [1 ,6 ,7 ]
机构
[1] Hlth Canada, HPFB, Biol & Genet Therapies Directorate, Ctr Vaccine Evaluat, Ottawa, ON K1A 0K9, Canada
[2] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada
[3] King Abdulaziz Univ, Fac Med, Dept Med Microbiol & Parasitol, Jeddah, Saudi Arabia
[4] King Abdulaziz Univ, King Fahd Ctr Med Res, Special Infect Agents Unit, Jeddah, Saudi Arabia
[5] Natl Inst Food & Drug Control, Beijing, Peoples R China
[6] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada
[7] Univ Ottawa, Emerging Pathogens Res Ctr, Ottawa, ON K1H 8M5, Canada
[8] WHO Collaborating Ctr Reference & Res Influenza, North Melbourne, Vic 3051, Australia
关键词
Neuraminidase; Universal antibody; Cross-protection; VIRUS-INFECTION; VIRAL NEURAMINIDASE; BROAD-SPECTRUM; PANDEMIC H1N1; HEMAGGLUTININ; PROTECTION; IMMUNIZATION; IMMUNITY; VACCINE; ENTRY;
D O I
10.1016/j.antiviral.2013.09.018
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The only universally conserved sequence amongst all influenza A viral neuraminidase (NA) is located between amino acids 222-230 and plays crucial roles in viral replication. However, it remained unclear as to whether this universal epitope is exposed during the course of infection to allow binding and inhibition by antibodies. Using a monoclonal antibody (MAb) targeting this specific epitope, we demonstrated that all nine subtypes of NA were inhibited in vitro by the MAb. Moreover, the antibody also provided heterosubtypic protection in mice challenged with lethal doses of mouse-adapted H1N1 and H3N2, which represent group I and II viruses, respectively. Furthermore, we report amino acid residues 1222 and E227, located in close proximity to the active site, are indispensable for inhibition by this antibody. This unique, highly-conserved linear sequence in viral NA could be an attractive immunological target for protection against diverse strains of influenza viruses. Crown Copyright (C) 2013 Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:567 / 574
页数:8
相关论文
共 50 条
  • [1] Anti-neuraminidase immunity in the combat against influenza
    Zhang, Xiaojian
    Ross, Ted M.
    EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 474 - 484
  • [2] Detection of anti-neuraminidase antibody in preclinical and clinical studies of live influenza vaccine
    Desheva, Yulia
    Smolonogina, Tatyana
    Rudenko, Larisa
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2011, 5 : 370 - 372
  • [3] An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivo
    Wilson, Jason R.
    Guo, Zhu
    Reber, Adrian
    Kamal, Ram P.
    Music, Nedzad
    Gansebom, Shane
    Bai, Yaohui
    Levine, Min
    Carney, Paul
    Tzeng, Wen-Pin
    Stevens, James
    York, Ian A.
    ANTIVIRAL RESEARCH, 2016, 135 : 48 - 55
  • [4] Serum anti-neuraminidase antibody responses in human influenza A(H1N1)pdm09 virus infections
    Karunarathna, Herath M. T. K.
    Perera, Ranawaka A. P. M.
    Fang, Vicky J.
    Yen, Hui-ling
    Cowling, Benjamin John
    Peiris, Malik
    EMERGING MICROBES & INFECTIONS, 2019, 8 (01): : 404 - 412
  • [5] Structure-Based Modification of an Anti-neuraminidase Human Antibody Restores Protection Efficacy against the Drifted Influenza Virus
    Jiang, Haihai
    Peng, Weiyu
    Qi, Jianxun
    Chai, Yan
    Song, Hao
    Bi, Yuhai
    Rijal, Pramila
    Wang, Haiyuan
    Oladejo, Babayemi O.
    Liu, Jinhua
    Shi, Yi
    Gao, George F.
    Townsend, Alain R.
    Wu, Yan
    MBIO, 2020, 11 (05): : 1 - 14
  • [6] Protective efficacy of anti-neuraminidase monoclonal antibodies against H7N9 influenza virus infection
    Xiong, Fei-Fei
    Liu, Xue-Ying
    Gao, Fei-Xia
    Luo, Jian
    Duan, Peng
    Tan, Wen-Song
    Chen, Ze
    EMERGING MICROBES & INFECTIONS, 2020, 9 (01) : 78 - 87
  • [7] Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals
    Desheva, Yulia
    Sychev, Ivan
    Smolonogina, Tatiana
    Rekstin, Andrey
    Ilyushina, Natalia
    Lugovtsev, Vladimir
    Samsonova, Anastasia
    Go, Aleksey
    Lerner, Anna
    PLOS ONE, 2018, 13 (05):
  • [8] Universal antibodies against the highly conserved influenza fusion peptide cross-neutralize several subtypes of influenza A virus
    Hashem, Anwar M.
    Van Domselaar, Gary
    Li, Changgui
    Wang, Junzhi
    She, Yi-Min
    Cyr, Terry D.
    Sui, Jianhua
    He, Runtao
    Marasco, Wayne A.
    Li, Xuguang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 403 (02) : 247 - 251
  • [9] Influenza neuraminidase-inhibiting antibodies are induced in the presence of zanamivir
    Sultana, Ishrat
    Gao, Jin
    Markoff, Lewis
    Eichelberger, Maryna C.
    VACCINE, 2011, 29 (14) : 2601 - 2606
  • [10] Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype
    Walz, Lisa
    Kays, Sarah-Katharina
    Zimmer, Gert
    von Messling, Veronika
    JOURNAL OF VIROLOGY, 2018, 92 (17)